erythromycin has been researched along with Respiratory Distress Syndrome, Newborn in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachilova, S; Berghella, V; Heidari, P; Hoffman, MK; Navathe, R; Roman, A; Schoen, CN; Smith, S; Tepper, J; Visintainer, P; Ward, A | 1 |
| Daigo, M; Shiga, S; Shimizu, T; Shinohara, K; Shoji, H; Suganuma, H; Umezaki, H; Yamashiro, Y | 1 |
| Gámez Guevara, C; Hernández y Ballinas, A; López Farán, JA | 1 |
| Hashimoto, T; Nishigaki, K; Okura, M; Ono, T; Sato, Y; Takeuchi, Y | 1 |
| Faxelius, G; Jónsson, B; Rylander, M | 1 |
| Dellagrammaticas, HD; Iacovidou, N; Kapetanakis, J; Megaloyanni, E; Papadimitriou, M | 1 |
3 trial(s) available for erythromycin and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
[Comparison of maternal and perinatal outcomes in the conservative treatment preterm premature membrane rupture between the use of erythromycin and clindamycin].
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Chorioamnionitis; Clindamycin; Endometritis; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infant, Premature, Diseases; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Respiratory Distress Syndrome, Newborn; Risk Factors; Sepsis; Urinary Tract Infections; Uterine Cervicitis; Young Adult | 2011 |
[Multicenter study on clinical effects of a small dose of erythromycin on chronic lung disorders of premature infants--single blind comparison of treated and untreated groups. A committee for the Study of EM Therapy for Chronic Lung Diseases of Premature
Topics: Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Erythromycin; Humans; Infant, Newborn; Respiratory Distress Syndrome, Newborn; Single-Blind Method | 1998 |
Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates.
Topics: Anti-Bacterial Agents; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Logistic Models; Male; Morbidity; Pregnancy; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Risk Factors; Ureaplasma Infections; Ureaplasma urealyticum | 1998 |
3 other study(ies) available for erythromycin and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Azithromycin vs erythromycin for the management of preterm premature rupture of membranes.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Chorioamnionitis; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Pregnancy; Respiratory Distress Syndrome, Newborn; Retrospective Studies | 2019 |
Hypertrophic pyloric stenosis in mono-ovular extremely preterm twins after use of erythromycin.
Topics: Digestive System Surgical Procedures; Diseases in Twins; Erythromycin; Gastrointestinal Agents; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Male; Pyloric Stenosis, Hypertrophic; Pylorus; Radiography; Respiratory Distress Syndrome, Newborn | 2008 |
Effect of low-dose oral erythromycin on gastric aspirates in ventilated neonates less than 32 weeks of gestation. Preliminary results.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Enteral Nutrition; Erythromycin; Gastrointestinal Agents; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Motilin; Prospective Studies; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Stomach; Suction | 2002 |